Vaccine Delivery Devices Market Size, Share, Trends, Growth 2032

Vaccine Delivery Devices Market Insights

Zion Market Research has published a report on the global Vaccine Delivery Devices Market, estimating its value at USD 6.83 Billion in 2023, with projections indicating that it will reach USD 14.29 Billion by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 7.7% over the forecast period 2024-2032. The report explores the factors fueling market growth, the hitches that could hamper this expansion, and the opportunities that may arise in the Vaccine Delivery Devices Market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

Request Free Sample

Global Vaccine Delivery Devices Market: Introduction

Vaccines are primary tools utilized for fighting contagious ailments. In spite of the vital significance of vaccines for improving public health, the accurate execution of vaccines has become a necessity and this is only possible through vaccine delivery devices. Apparently, there is a high focus of healthcare service professionals on vaccine delivery equipment for improving antigen stability and immunogenicity. Moreover, vaccine delivery equipment provides myriad benefits over injectable vaccines such as self-administration, stability, cost-reduction, and cold chain elimination. With the rise in COVID-19 cases, the vaccine delivery devices industry is likely to gain momentum over the upcoming years.

Global Vaccine Delivery Devices Market: Growth Drivers

With vaccine delivery devices incorporating a large number of antigens as compared to slowly antigen-releasing booster doses, the vaccine delivery devices industry is anticipated to expand rapidly over the ensuing years. The surge in the immunization programs' rising government aid along with the production of new vaccines will steer the market size over the assessment period. The rapid increase in immunization coverage and financial aid from international authorities will prompt the business landscape over the ensuing years.

Request Free Sample

Furthermore, large-scale use of needle-free delivery equipment will produce lucrative growth avenues for the vaccine delivery devices market over the forecast period. Apart from this, swift breakthroughs in vaccine delivery systems like microneedles for subcutaneous injection as well as electroporation will mark a new era in the growth of the vaccine delivery devices industry over the forecasting years. However, the high costs of vaccine delivery devices can pose a threat to the growth of the vaccine delivery devices industry in the years ahead.

Vaccine Delivery Devices Market: Report Scope

Global Vaccine Delivery Devices Market Regional Landscape

North America To Dominate Global Market Landscape Over 2024-2032

The expansion of the vaccine delivery devices industry in the North American sub-continent over the assessment period is attributed to bulging immunization coverage along with rising funding for research activities for producing new kinds of vaccines. Apart from this, the presence of robust healthcare infrastructure in the sub-continent will create new horizons of growth for the vaccine delivery devices industry over the estimated timespan. Huge awareness about the products among the regional population and healthcare service providers will pave a way for the emergence of the business landscape in the region in the coming decade. U.S. and Canada are projected to be major regional revenue pockets in the upcoming years.

Key Market Players & Competitive Landscape

Key participants profiled in the report include 

• SCHOTT AG
• Becton Dickinson & Company
• PharmaJet
• Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
• Corium International, Inc.
• Vaxxas
• Gerresheimer AG
• 3M

The global Vaccine Delivery Devices Market is segmented as follows:

 By Devices  

• Syringes
• Jet Injectors
• Other Devices

By Route of Administration

•  Intradermal Vaccination
•  Intramuscular Vaccination
•  Subcutaneous Vaccination

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa